Quilmes, Argentina

Santiago Giron

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Romikin S.a., Universidad Nacional De Quilmes. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Santiago Giron. Retrieved from https://idiyas.com/inventor/santiago-giron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Santiago Giron: Innovator in Anti-Diuretic Research

Introduction

Santiago Giron is a notable inventor based in Quilmes, Argentina. He has made significant contributions to the field of medical research, particularly in the development of analogs for anti-diuretic purposes. His work has implications for cancer treatment and the inhibition of metastasis.

Latest Patents

Santiago Giron holds a patent for "1-desamino-8-D-arginyl vasopressin analogs." This patent involves analogs of 1-desamino-8-D-arginyl vasopressin, which are defined by a specific formula. These compounds are useful as anti-diuretics and as inhibitors of metastasis and cancer cell migration. He has 1 patent to his name.

Career Highlights

Throughout his career, Santiago has worked with esteemed institutions such as Universidad Nacional De Quilmes and Romikin S.A. His research has focused on innovative solutions to pressing medical challenges, particularly in the realm of cancer treatment.

Collaborations

Santiago has collaborated with notable colleagues, including Daniel Eduardo Gomez and Daniel Fernando Alonso. Their combined expertise has contributed to advancements in their respective fields.

Conclusion

Santiago Giron is a distinguished inventor whose work in anti-diuretic research has the potential to impact cancer treatment significantly. His contributions to the field are noteworthy and reflect his dedication to innovation in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…